Back to VANGUARD GROUP INC VANGUARD GROUP INC

TELOTELO
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in TELOMIR PHARMACEUTICALS INC

As of its last 13F, for Q4 2025, Vanguard Group held 1,137,466 shares of TELO (Telomir Pharmaceuticals), worth $1.5M. It increased the position by 35,714 shares (+3.2%) from Q3 2025. Vanguard Group held TELO from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$1.5M

Current Shares

1.1M

Total Value Change

-$5.9M

Total Shares Change

-14,061

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
1.1M
+3.2%
$1.5M0.0%$1.33
18
2025-Q3
Decreased
1.1M
-1.5%
$1.5M0.0%$1.39
0
2025-Q2
Decreased
1.1M
-11.1%
$1.4M0.0%$1.25
0
2025-Q1
Decreased
1.3M
-0.8%
$4.1M0.0%$3.23
0
2024-Q4
Increased
1.3M
+10.2%
$5.2M0.0%$4.12
30
2024-Q3
First report
1.2M
-
$7.4M0.0%$6.42
0

Other major holders of TELO: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used